No ASX ETF holds EBR Systems (EBR) as of 15 Oct 2026. Over the last 3 months it fell 62.7%: on $10,000, −$6267. We explain 3 big moves in that time.
About EBR
- SectorHealth Care
- IndustryHealth Care Equipment & Services
- Size$131.0m
- Held by0 ETFs
- Big moves3 in 3M
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +18.4%peak +20.4%28 Jul 2026· Sector Flow
EBR Systems likely rose on broad strength across the ASX healthcare sector, which gained around 2% on the same day, lifting smaller healthcare stocks disproportionately.
- −18.3%peak −20.0%27 Jul 2026· Regulatory
EBR Systems fell ~17% as investors sold off despite a new US product launch, with the market focused instead on the pending Medicare coverage decision that remains unresolved and critical to the company's commercial success.
- −3.2%peak −14.5%24 Jul 2026· Regulatory
A reported serious adverse event linked to EBR's WiSE wireless cardiac pacing system spooked investors, overshadowing a positive product launch announcement and driving a sharp sell-off.
Held by 0 ETFs
No ETF we track holds EBR directly.
Other Health Care companies
- SHLSonic Healthcare47 ETFs
- RMDResMed44 ETFs
- CSLCSL Limited42 ETFs
- BDXBcal36 ETFs
- CSXCleanspace36 ETFs
- REGRegis Health33 ETFs
- TLXTelix Pharma32 ETFs
- SIGSigma Healthcare31 ETFs
Why did EBR fall 18.3% on 27 Jul 2026?
EBR Systems
EBR Systems fell ~17% as investors sold off despite a new US product launch, with the market focused instead on the pending Medicare coverage decision that remains unresolved and critical to the company's commercial success.
The Kalkine headline directly asks 'What Has Investors Spooked?' in the context of a US product launch failing to lift the stock, and an earlier article from July 21 explicitly flags investor concern about an awaited Medicare coverage decision — suggesting the market views the product launch as irrelevant without reimbursement clarity. The ASX announcement was a routine Appendix 2A for option conversions into CDIs (non-material dilution), which is a minor negative but unlikely to drive a 16.67% move alone. The health sector index was actually up 1.4% on the same day, confirming this is company-specific rather than sector-driven, and the high volume (3.9x) and 5.2x ATR move are consistent with a sentiment-driven selloff on unresolved regulatory/reimbursement risk.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
Company announcements
News coverage
Sector / macro signals